Δ32 mutation of the chemokine-receptor 5 gene in inflammatory bowel disease

被引:11
作者
Martin, K
Heinzlmann, M
Borchers, R
Mack, M
Loeschke, K
Folwaczny, C
机构
[1] Univ Munich, Standort Innenstadt, Med Klin, Munich, Germany
[2] Univ Munich, Standort Innenstadt, Poliklin, Munich, Germany
关键词
inflammatory bowel disease; Delta; 32; mutation; chemokine receptor 5; p-ANCA;
D O I
10.1006/clim.2000.4943
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The gene encoding chemokine receptor 5 (CCR5) is colocalized to the microsatellite marker D3S1573, which was linked with inflammatory bowel disease. Genetic heterogeneity in inflammatory bowel disease might be defined by a combination of the p-ANCA status and immunoregulatory genes. One hundred and twenty healthy unrelated controls, 101 patients with Crohn's disease, and 99 patients with ulcerative colitis were genotyped for the Delta 32 mutation of the CCR5 gene. The presence of p-ANCA was determined by the use of indirect immunofluorescence. After genotyping, patients were stratified according to p-ANCA status. The frequency of the Delta 32 mutation was not significantly different in controls and patients with Crohn's disease or ulcerative colitis (P 0.207 or more). Moreover, the frequency of the mutation was not significantly different in patients with inflammatory bowel disease after stratification for the p-ANCA status (P 0.482). Regardless of the p-ANCA status, Crohn's disease and ulcerative colitis are not associated with the Delta 32 mutation of the CCR5 gene. (C) 2000 Academic Press.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 41 条
  • [1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [2] Human chemokines: An update
    Baggiolini, M
    Dewald, B
    Moser, B
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 675 - 705
  • [3] ANTINEUTROPHIL ANTIBODIES IN INFLAMMATORY BOWEL-DISEASE - PREVALENCE AND DIAGNOSTIC ROLE
    CAMBRIDGE, G
    RAMPTON, DS
    STEVENS, TRJ
    MCCARTHY, DA
    KAMM, M
    LEAKER, B
    [J]. GUT, 1992, 33 (05) : 668 - 674
  • [4] Novel alleles of the chemokine-receptor gene CCR5
    Carrington, M
    Kissner, T
    Gerrard, B
    Ivanov, S
    O'Brien, SJ
    Dean, M
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (06) : 1261 - 1267
  • [5] Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1q, 3q, and 4q:: Evidence for epistasis between 1p and IBD1
    Cho, JH
    Nicolae, DL
    Gold, LH
    Fields, CT
    LaBuda, MC
    Rohal, PM
    Pickles, MR
    Qin, L
    Fu, YF
    Mann, JS
    Kirschner, BS
    Jabs, EW
    Weber, J
    Hanauer, SB
    Bayless, TM
    Brant, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) : 7502 - 7507
  • [6] Cho JH, 1997, GASTROENTEROLOGY, V112, pA948
  • [7] SOLUBLE INTERLEUKIN-2 RECEPTORS, ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES, AND OTHER AUTOANTIBODIES IN PATIENTS WITH ULCERATIVE-COLITIS
    DALEKOS, GN
    MANOUSSAKIS, MN
    GOUSSIA, AC
    TSIANOS, EV
    MOUTSOPOULOS, HM
    [J]. GUT, 1993, 34 (05) : 658 - 664
  • [8] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
    Dean, M
    Carrington, M
    Winkler, C
    Huttley, GA
    Smith, MW
    Allikmets, R
    Goedert, JJ
    Buchbinder, SP
    Vittinghoff, E
    Gomperts, E
    Donfield, S
    Vlahov, D
    Kaslow, R
    Saah, A
    Rinaldo, C
    Detels, R
    OBrien, SJ
    [J]. SCIENCE, 1996, 273 (5283) : 1856 - 1862
  • [9] Folwaczny C, 1998, SCAND J GASTROENTERO, V33, P523
  • [10] FOLWACZNY C, 1998, Z GASTROENTEROL, V36, P791